Cytokinetics (CYTK) Statistics & Valuation Metrics - Stocknear

Cytokinetics

NASDAQ: CYTK · Real-Time Price · USD
53.01
3.26 (6.55%)
At close: Sep 05, 2025, 3:59 PM
52.03
-1.85%
After-hours: Sep 05, 2025, 07:32 PM EDT

Cytokinetics Statistics

Share Statistics

Cytokinetics has 119.66M shares outstanding. The number of shares has increased by 1.5% in one year.

119.66M
1.5%
0.86%
99.99%
117M
54
n/a

Short Selling Information

The latest short interest is 15.33M, so 12.81% of the outstanding shares have been sold short.

15.33M
12.81%
16.7%
9.62

Valuation Ratios

The PE ratio is -8.94 and the forward PE ratio is -8.7. Cytokinetics's PEG ratio is 2.56.

-8.94
-8.7
285.13
43.4
-38.91
-13.18
2.56
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cytokinetics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 6.17, with a Debt / Equity ratio of -5.83.

6.17
6.17
-5.83
-1.6
-1.97
-6.2

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$37.1K
$-1.18M
498
0.01
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -2% in the last 52 weeks. The beta is 0.62, so Cytokinetics's price volatility has been higher than the market average.

0.62
-2%
37.6
41.15
77.95
1,767,790

Income Statement

In the last 12 months, Cytokinetics had revenue of 18.47M and earned -589.53M in profits. Earnings per share was -5.26.

18.47M
-320.93M
-536.25M
-589.53M
-493.48M
-503.01M
-5.26
Full Income Statement

Balance Sheet

The company has 94.86M in cash and 788.68M in debt, giving a net cash position of -693.82M.

94.86M
788.68M
-693.82M
-2.7B
1.23B
755.48M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -395.89M and capital expenditures -3.91M, giving a free cash flow of -399.8M.

-395.89M
-3.91M
-399.8M
-3.57
Full Cash Flow Statement

Margins

Gross margin is -1737.22%, with operating and profit margins of -2902.72% and -3191.11%.

-1737.22%
-2902.72%
-3191.11%
-3191.11%
-2671.23%
-2902.72%
-2164.1%

Dividends & Yields

CYTK does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for CYTK is $78, which is 47.1% higher than the current price. The consensus rating is "Buy".

$78
47.1%
Buy
15
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jun 25, 2013. It was a backward split with a ratio of 1:6.

Jun 25, 2013
backward
1:6

Scores

-1.76
3